NCI | Technology Transfer

ANTIVIRAL COMPOSITIONS AND METHODS

Read more about ANTIVIRAL COMPOSITIONS AND METHODS

United Kingdom
86306495.2
Filed on 1986-08-08

ANTIVIRAL COMPOSITIONS AND METHODS

Read more about ANTIVIRAL COMPOSITIONS AND METHODS

Switzerland
86306495.2
Filed on 1986-08-08

ANTIVIRAL COMPOSITIONS AND METHODS

Read more about ANTIVIRAL COMPOSITIONS AND METHODS

Sweden
86306495.2
Filed on 1986-08-08

ANTIVIRAL COMPOSITIONS AND METHODS

Read more about ANTIVIRAL COMPOSITIONS AND METHODS

Singapore
9590585.7
Filed on 1986-08-08

INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2'3'-DIDEOXYCYTIDINE

Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2'3'-DIDEOXYCYTIDINE

New Zealand
217184
Filed on 1986-08-13

ANTIVIRAL COMPOSITIONS AND METHODS

Read more about ANTIVIRAL COMPOSITIONS AND METHODS

Luxembourg
86306495.2
Filed on 1986-08-08

INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'- DIDEOXYINOSINE

Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'- DIDEOXYINOSINE

Switzerland
86306494.5
Filed on 1986-08-21

INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3' - DIDEOXYINOSINE

Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3' - DIDEOXYINOSINE

Sweden
86306494.5
Filed on 1986-08-21

INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'- DIDEOXYINOSINE

Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'- DIDEOXYINOSINE

Singapore
9490322-6
Filed on 1986-08-21

INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-DIDEOXYGUANOSINE OR 2'3'-DIDEOXYADENOSINE

Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-DIDEOXYGUANOSINE OR 2'3'-DIDEOXYADENOSINE

New Zealand
217185
Filed on 1986-08-13

Subscribe to NCI